𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutated and non-mutated TP53 as targets in the treatment of leukaemia

✍ Scribed by H. Nahi; G. Selivanova; S. Lehmann; L. Möllgård; S. Bengtzen; H. Concha; A. Svensson; K. G. Wiman; M. Merup; C. Paul


Book ID
108675664
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
405 KB
Volume
141
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The spectrum of TP53 mutations in bladde
✍ Magali P. Williamson; Patricia A. Elder; Margaret A. Knowles 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

The mutational spectrum for the TP53 gene was investigated in a large series of bladder tumors and bladder tumor cell lines. Tumors and cell lines were screened for the presence of TP53 point mutations by single-strand conformational polymorphism analysis followed by direct sequencing. Mutations wer

Reassessment of the TP53 mutation databa
✍ Thierry Soussi; Shunsuke Kato; Pierre P. Levy; Chikashi Ishioka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

## Communicated by A. Jamie Cuticchia TP53 alteration is the most frequent genetic alteration found in human cancers. To date, more than 15,000 tumors with TP53 mutations have been published, leading to the description of more than 1,500 different TP53 mutants (http://p53.curie.fr). The frequency o

TP53 is frequently altered by methylatio
✍ Xabier Agirre; Francisco J. Novo; María J. Calasanz; María J. Larráyoz; Idoya La 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract Different mechanisms, such as chromosomal rearrangements, deletions, mutations, and methylation/demethylation of the promoter regions of genes, have been shown to be involved in acute lymphoblastic leukaemia (ALL). These genetic and epigenetic alterations lead to the activation of proto